John W. Schoggins, Ph.D. - Publications

Affiliations: 
2007 Weill Cornell Medical College, New York, NY, United States 
Area:
Molecular Biology, Microbiology Biology, Immunology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lee EE, Mejia M, Matthews LA, Lee F, Shah KM, Schoggins JW, Vandergriff TW, Yancey KB, Thomas C, Wang RC. West Nile virus encephalitis presenting with a vesicular dermatitis. Jaad Case Reports. 45: 117-122. PMID 38464779 DOI: 10.1016/j.jdcr.2023.12.016  0.346
2023 Carreno-Florez GP, Kocak BR, Hendricks MR, Melvin JA, Mar KB, Kosanovich J, Cumberland RL, Delgoffe GM, Shiva S, Empey KM, Schoggins JW, Bomberger JM. Interferon signaling drives epithelial metabolic reprogramming to promote secondary bacterial infection. Plos Pathogens. 19: e1011719. PMID 37939149 DOI: 10.1371/journal.ppat.1011719  0.777
2023 Kober DL, Caballero Van Dyke MC, Eitson JL, Boys IN, McDougal MB, Rosenbaum DM, Schoggins JW. Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo. Biorxiv : the Preprint Server For Biology. PMID 37808801 DOI: 10.1101/2023.09.26.559550  0.305
2023 McDougal MB, De Maria AM, Ohlson MB, Kumar A, Xing C, Schoggins JW. Interferon inhibits a model RNA virus via a limited set of inducible effector genes. Embo Reports. e56901. PMID 37497756 DOI: 10.15252/embr.202356901  0.482
2023 Mar KB, Wells AI, Caballero Van Dyke MC, Lopez AH, Eitson JL, Fan W, Hanners NW, Evers BM, Shelton JM, Schoggins JW. LY6E is a pan-coronavirus restriction factor in the respiratory tract. Nature Microbiology. PMID 37443277 DOI: 10.1038/s41564-023-01431-w  0.772
2023 Ahmed MS, Farag AB, Boys IN, Wang P, Menendez-Montes I, Nguyen NUN, Eitson JL, Ohlson MB, Fan W, McDougal MB, Mar K, Thet S, Ortiz F, Kim SY, Solmonson A, ... ... Schoggins JW, et al. FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 162: 114614. PMID 37068330 DOI: 10.1016/j.biopha.2023.114614  0.728
2023 McDougal MB, De Maria AM, Ohlson MB, Kumar A, Xing C, Schoggins JW. Interferon inhibits a model RNA virus via a limited set of inducible effector genes. Biorxiv : the Preprint Server For Biology. PMID 36865157 DOI: 10.1101/2023.02.21.529297  0.482
2023 Ohlson MB, Eitson JL, Wells AI, Kumar A, Jang S, Ni C, Xing C, Buszczak M, Schoggins JW. Genome-Scale CRISPR Screening Reveals Host Factors Required for Ribosome Formation and Viral Replication. Mbio. e0012723. PMID 36809113 DOI: 10.1128/mbio.00127-23  0.369
2023 Rehfeld F, Eitson JL, Ohlson MB, Chang TC, Schoggins JW, Mendell JT. CRISPR screening reveals a dependency on ribosome recycling for efficient SARS-CoV-2 programmed ribosomal frameshifting and viral replication. Cell Reports. 42: 112076. PMID 36753415 DOI: 10.1016/j.celrep.2023.112076  0.322
2023 Mar KB, Van Dyke MC, Lopez AH, Eitson JL, Fan W, Hanners NW, Evers BM, Shelton JM, Schoggins JW. LY6E protects mice from pathogenic effects of murine coronavirus and SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 36747632 DOI: 10.1101/2023.01.25.525551  0.762
2022 Fan W, McDougal MB, Schoggins JW. Enterovirus 3C Protease Cleaves TRIM7 To Dampen Its Antiviral Activity. Journal of Virology. e0133222. PMID 36106874 DOI: 10.1128/jvi.01332-22  0.395
2022 Kumata R, Iwanami S, Mar KB, Kakizoe Y, Misawa N, Nakaoka S, Koyanagi Y, Perelson AS, Schoggins JW, Iwami S, Sato K. Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection. Plos Computational Biology. 18: e1010053. PMID 35468127 DOI: 10.1371/journal.pcbi.1010053  0.785
2022 McDougal MB, Boys IN, De La Cruz-Rivera P, Schoggins JW. Evolution of the interferon response: lessons from ISGs of diverse mammals. Current Opinion in Virology. 53: 101202. PMID 35124511 DOI: 10.1016/j.coviro.2022.101202  0.395
2021 Hanners NW, Mar KB, Boys IN, Eitson JL, De La Cruz-Rivera PC, Richardson RB, Fan W, Wight-Carter M, Schoggins JW. Shiftless inhibits flavivirus replication in vitro and is neuroprotective in a mouse model of Zika virus pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34873063 DOI: 10.1073/pnas.2111266118  0.804
2021 Rinkenberger N, Abrams ME, Matta SK, Schoggins JW, Alto NM, Sibley LD. Over-expression screen of interferon-stimulated genes identifies RARRES3 as a restrictor of infection. Elife. 10. PMID 34871166 DOI: 10.7554/eLife.73137  0.366
2021 Fan W, Mar KB, Sari L, Gaszek IK, Cheng Q, Evers BM, Shelton JM, Wight-Carter M, Siegwart DJ, Lin MM, Schoggins JW. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell. PMID 34062120 DOI: 10.1016/j.cell.2021.04.047  0.797
2021 Boys IN, Mar KB, Schoggins JW. Functional-genomic analysis reveals intraspecies diversification of antiviral receptor transporter proteins in Xenopus laevis. Plos Genetics. 17: e1009578. PMID 34014925 DOI: 10.1371/journal.pgen.1009578  0.753
2020 Dong X, Yang Y, Zou Z, Zhao Y, Ci B, Zhong L, Bhave M, Wang L, Kuo YC, Zang X, Zhong R, Aguilera ER, Richardson RB, Simonetti B, Schoggins JW, et al. Sorting nexin 5 mediates virus-induced autophagy and immunity. Nature. PMID 33328639 DOI: 10.1038/s41586-020-03056-z  0.474
2020 Boys IN, Xu E, Mar KB, De La Cruz-Rivera PC, Eitson JL, Moon B, Schoggins JW. RTP4 Is a Potent IFN-Inducible Anti-flavivirus Effector Engaged in a Host-Virus Arms Race in Bats and Other Mammals. Cell Host & Microbe. PMID 33113352 DOI: 10.1016/j.chom.2020.09.014  0.792
2020 Zhu J, Kim J, Xiao X, Wang Y, Luo D, Jiang S, Chen R, Xu L, Zhang H, Moise L, Gutierrez AH, De Groot AS, Xiao G, Schoggins JW, Zhan X, et al. The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 32908981 DOI: 10.1101/2020.02.08.939553  0.309
2020 Pfaender S, Mar KB, Michailidis E, Kratzel A, Boys IN, V'kovski P, Fan W, Kelly JN, Hirt D, Ebert N, Stalder H, Kleine-Weber H, Hoffmann M, Heinrich Hoffmann H, Saeed M, ... ... Schoggins JW, et al. LY6E impairs coronavirus fusion and confers immune control of viral disease. Nature Microbiology. PMID 32704094 DOI: 10.1038/S41564-020-0769-Y  0.812
2020 Kuroda M, Halfmann PJ, Hill-Batorski L, Ozawa M, Lopes TJS, Neumann G, Schoggins JW, Rice CM, Kawaoka Y. Identification of interferon-stimulated genes that attenuate Ebola virus infection. Nature Communications. 11: 2953. PMID 32528005 DOI: 10.1038/S41467-020-16768-7  0.559
2020 Pfaender S, Mar KB, Michailidis E, Kratzel A, Hirt D, V'kovski P, Fan W, Ebert N, Stalder H, Kleine-Weber H, Hoffmann M, Hoffmann HH, Saeed M, Dijkman R, Steinmann E, ... ... Schoggins JW, et al. LY6E impairs coronavirus fusion and confers immune control of viral disease. Biorxiv : the Preprint Server For Biology. PMID 32511345 DOI: 10.1101/2020.03.05.979260  0.802
2020 Ramanathan HN, Zhang S, Douam F, Mar KB, Chang J, Yang PL, Schoggins JW, Ploss A, Lindenbach BD. A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating. Mbio. 11. PMID 32291299 DOI: 10.1128/Mbio.00467-20  0.786
2020 Abrams ME, Johnson KA, Perelman SS, Zhang LS, Endapally S, Mar KB, Thompson BM, McDonald JG, Schoggins JW, Radhakrishnan A, Alto NM. Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol. Nature Microbiology. PMID 32284563 DOI: 10.1038/S41564-020-0701-5  0.745
2020 Farag A, Wang P, Boys IN, Eitson JL, Ohlson MB, Fan W, McDougal MB, Ahmed M, Schoggins JW, Sadek H. Identification of Atovaquone, Ouabain and Mebendazole as FDA Approved Drugs Tar-geting SARS-CoV-2 (Version 4) Chemrxiv. DOI: 10.26434/Chemrxiv.12003930.V4  0.323
2019 Schoggins JW. Interferon-Stimulated Genes: What Do They All Do? Annual Review of Virology. PMID 31283436 DOI: 10.1146/Annurev-Virology-092818-015756  0.461
2019 Rinkenberger N, Schoggins JW. Comparative analysis of viral entry for Asian and African lineages of Zika virus. Virology. 533: 59-67. PMID 31112915 DOI: 10.1016/J.Virol.2019.04.008  0.448
2019 Lazear HM, Schoggins JW, Diamond MS. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 50: 907-923. PMID 30995506 DOI: 10.1016/J.Immuni.2019.03.025  0.39
2019 Liu Z, Mar KB, Hanners NW, Perelman SS, Kanchwala M, Xing C, Schoggins JW, Alto NM. A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB. Nature. PMID 30894749 DOI: 10.1038/S41586-019-1041-6  0.737
2019 Hubel P, Urban C, Bergant V, Schneider WM, Knauer B, Stukalov A, Scaturro P, Mann A, Brunotte L, Hoffmann HH, Schoggins JW, Schwemmle M, Mann M, Rice CM, Pichlmair A. A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nature Immunology. PMID 30833792 DOI: 10.1038/S41590-019-0323-3  0.423
2018 Richardson RB, Ohlson MB, Eitson JL, Kumar A, McDougal MB, Boys IN, Mar KB, De La Cruz-Rivera PC, Douglas C, Konopka G, Xing C, Schoggins JW. A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication. Nature Microbiology. PMID 30224801 DOI: 10.1038/S41564-018-0244-1  0.789
2018 Mar KB, Rinkenberger NR, Boys IN, Eitson JL, McDougal MB, Richardson RB, Schoggins JW. LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. Nature Communications. 9: 3603. PMID 30190477 DOI: 10.1038/S41467-018-06000-Y  0.82
2018 Schoggins JW. Recent advances in antiviral interferon-stimulated gene biology. F1000research. 7: 309. PMID 29568506 DOI: 10.12688/F1000Research.12450.1  0.463
2018 Rinkenberger N, Schoggins JW. Mucolipin-2 Cation Channel Increases Trafficking Efficiency of Endocytosed Viruses. Mbio. 9. PMID 29382735 DOI: 10.1128/Mbio.02314-17  0.527
2018 De La Cruz-Rivera PC, Kanchwala M, Liang H, Kumar A, Wang LF, Xing C, Schoggins JW. The IFN Response in Bats Displays Distinctive IFN-Stimulated Gene Expression Kinetics with Atypical RNASEL Induction. Journal of Immunology (Baltimore, Md. : 1950). 200: 209-217. PMID 29180486 DOI: 10.4049/Jimmunol.1701214  0.548
2017 Rosenberg BR, Freije CA, Imanaka N, Chen ST, Eitson JL, Caron R, Uhl SA, Zeremski M, Talal A, Jacobson IM, Rice CM, Schoggins JW. Genetic variation at IFNL4 influences extrahepatic interferon stimulated gene expression in chronic HCV patients. The Journal of Infectious Diseases. PMID 29165633 DOI: 10.1093/Infdis/Jix593  0.351
2017 Lipovsky A, Erden A, Kanaya E, Zhang W, Crite M, Bradfield C, MacMicking J, DiMaio D, Schoggins JW, Iwasaki A. The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry. The Journal of General Virology. PMID 29058661 DOI: 10.1099/Jgv.0.000954  0.309
2016 Perelman SS, Abrams ME, Eitson JL, Chen D, Jimenez A, Mettlen M, Schoggins JW, Alto NM. Cell-Based Screen Identifies Human Interferon-Stimulated Regulators of Listeria monocytogenes Infection. Plos Pathogens. 12: e1006102. PMID 28002492 DOI: 10.1371/Journal.Ppat.1006102  0.495
2016 Kane M, Zang TM, Rihn SJ, Zhang F, Kueck T, Alim M, Schoggins J, Rice CM, Wilson SJ, Bieniasz PD. Identification of Interferon-Stimulated Genes with Antiretroviral Activity. Cell Host & Microbe. 20: 392-405. PMID 27631702 DOI: 10.1016/J.Chom.2016.08.005  0.477
2016 Hanners NW, Eitson JL, Usui N, Richardson RB, Wexler EM, Konopka G, Schoggins JW. Western Zika Virus in Human Fetal Neural Progenitors Persists Long Term with Partial Cytopathic and Limited Immunogenic Effects. Cell Reports. PMID 27268504 DOI: 10.1016/J.Celrep.2016.05.075  0.482
2016 Mar KB, Schoggins JW. NLRX1 Helps HIV Avoid a STING Operation. Cell Host & Microbe. 19: 430-1. PMID 27078064 DOI: 10.1016/J.Chom.2016.03.011  0.734
2015 Schoggins JW. A phospholipase linkAGE to SARS susceptibility. The Journal of Experimental Medicine. 212: 1755. PMID 26482140 DOI: 10.1084/Jem.21211Insight2  0.372
2015 Schoggins JW. IMMUNOLOGY. Viruses carry antiviral cargo. Science (New York, N.Y.). 349: 1166-7. PMID 26359389 DOI: 10.1126/Science.Aad0942  0.489
2015 Schoggins JW. A Sense of Self: RIG-I's Tolerance to Host RNA. Immunity. 43: 1-2. PMID 26200004 DOI: 10.1016/J.Immuni.2015.06.022  0.313
2015 Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. PMID 26153858 DOI: 10.1038/Nature14554  0.342
2015 Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, et al. Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature. 525: 144. PMID 26153856 DOI: 10.1038/Nature14555  0.791
2014 Schoggins JW. Interferon-stimulated genes: roles in viral pathogenesis. Current Opinion in Virology. 6: 40-6. PMID 24713352 DOI: 10.1016/J.Coviro.2014.03.006  0.51
2014 Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature. 505: 691-5. PMID 24284630 DOI: 10.1038/Nature12862  0.804
2013 Schoggins JW, Randall G. Lipids in innate antiviral defense. Cell Host & Microbe. 14: 379-85. PMID 24139397 DOI: 10.1016/J.Chom.2013.09.010  0.462
2013 Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature. 502: 563-6. PMID 24121441 DOI: 10.1038/Nature12653  0.333
2013 Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, Rice CM, Jackson MW, Junk DJ, Stark GR. IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. The Embo Journal. 32: 2751-63. PMID 24065129 DOI: 10.1038/Emboj.2013.203  0.407
2013 Diamond MS, Schoggins JW. Host restriction factor screening: let the virus do the work. Cell Host & Microbe. 14: 229-31. PMID 24034609 DOI: 10.1016/J.Chom.2013.08.014  0.479
2013 Schoggins JW, Rice CM. Innate immune responses to hepatitis C virus. Current Topics in Microbiology and Immunology. 369: 219-42. PMID 23463203 DOI: 10.1007/978-3-642-27340-7_9  0.449
2012 Wilson SJ, Schoggins JW, Zang T, Kutluay SB, Jouvenet N, Alim MA, Bitzegeio J, Rice CM, Bieniasz PD. Inhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesterase. Cell Host & Microbe. 12: 585-97. PMID 23084924 DOI: 10.1016/J.Chom.2012.08.012  0.402
2012 Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, Rice CM. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proceedings of the National Academy of Sciences of the United States of America. 109: 14610-5. PMID 22908290 DOI: 10.1073/Pnas.1212379109  0.481
2012 Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong XF, Kreins A, ... ... Schoggins JW, et al. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science (New York, N.Y.). 337: 1684-8. PMID 22859821 DOI: 10.1126/Science.1224026  0.458
2012 Karki S, Li MM, Schoggins JW, Tian S, Rice CM, MacDonald MR. Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity. Plos One. 7: e37398. PMID 22615998 DOI: 10.1371/Journal.Pone.0037398  0.506
2012 Meng X, Schoggins J, Rose L, Cao J, Ploss A, Rice CM, Xiang Y. C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1. Journal of Virology. 86: 4538-47. PMID 22345458 DOI: 10.1128/Jvi.06140-11  0.504
2012 Schoggins J. I04 Identification and characterization of antiviral interferon effectors across the viral phylogeny Cytokine. 59: 491-492. DOI: 10.1016/J.Cyto.2012.06.294  0.535
2011 Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Current Opinion in Virology. 1: 519-25. PMID 22328912 DOI: 10.1016/J.Coviro.2011.10.008  0.502
2011 Andrus L, Marukian S, Jones CT, Catanese MT, Sheahan TP, Schoggins JW, Barry WT, Dustin LB, Trehan K, Ploss A, Bhatia SN, Rice CM. Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (Baltimore, Md.). 54: 1901-12. PMID 22144107 DOI: 10.1002/Hep.24557  0.459
2011 Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A. A genetically humanized mouse model for hepatitis C virus infection. Nature. 474: 208-11. PMID 21654804 DOI: 10.1038/Nature10168  0.417
2011 Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 472: 481-5. PMID 21478870 DOI: 10.1038/Nature09907  0.544
2011 Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. PS1-122 Unraveling the complexity of the type I interferon antiviral response Cytokine. 56: 48. DOI: 10.1016/J.Cyto.2011.07.155  0.303
2010 Kohaar I, Ploss A, Korol E, Mu K, Schoggins JW, O'Brien TR, Rice CM, Prokunina-Olsson L. Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry. Journal of Virology. 84: 6987-94. PMID 20463075 DOI: 10.1128/Jvi.00196-10  0.39
2010 Jones CT, Catanese MT, Law LM, Khetani SR, Syder AJ, Ploss A, Oh TS, Schoggins JW, MacDonald MR, Bhatia SN, Rice CM. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nature Biotechnology. 28: 167-71. PMID 20118917 DOI: 10.1038/Nbt.1604  0.404
2009 Schoggins JW, Falck-Pedersen E. Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber. Virology. 395: 10-20. PMID 19782383 DOI: 10.1016/J.Virol.2009.08.041  0.678
2009 Diaz F, Gravotta D, Deora A, Schreiner R, Schoggins J, Falck-Pedersen E, Rodriguez-Boulan E. Clathrin adaptor AP1B controls adenovirus infectivity of epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 11143-8. PMID 19549835 DOI: 10.1073/Pnas.0811227106  0.696
2007 Gall J, Schoggins J, Falck-Pedersen E. Adenovirus capsid chimeras: fiber terminal exon insertions/gene replacements in the major late transcription unit. Methods in Molecular Medicine. 130: 107-23. PMID 17401167 DOI: 10.1385/1-59745-166-5:107  0.7
2007 Nociari M, Ocheretina O, Schoggins JW, Falck-Pedersen E. Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. Journal of Virology. 81: 4145-57. PMID 17251283 DOI: 10.1128/Jvi.02685-06  0.758
2006 Schoggins JW, Falck-Pedersen E. Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity. Journal of Virology. 80: 10634-44. PMID 16943295 DOI: 10.1128/Jvi.01359-06  0.71
2005 Schoggins JW, Nociari M, Philpott N, Falck-Pedersen E. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation. Journal of Virology. 79: 11627-37. PMID 16140740 DOI: 10.1128/Jvi.79.18.11627-11637.2005  0.7
2003 Schoggins JW, Gall JG, Falck-Pedersen E. Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. Journal of Virology. 77: 1039-48. PMID 12502819 DOI: 10.1128/Jvi.77.2.1039-1048.2003  0.652
Show low-probability matches.